As I am writing this, a revolution in medicine and science is building up steam around the world called Genomics. Let me clue you in so you do not miss the boat on this dramatic change coming in our lives. Genomics means the study of genomes. A genome is the complete sequence of an organism’s DNA, […]
The Genomics Revolution: move over blood type, here comes your genotype Read More »
What will we define as a success for any given stem cell biotech like ViaCyte? In academia, even if we do pre-clinical, translational kind of biomedical sciences, we still do not often think about what it takes to succeed in industry. Even if we very much want our research to make a difference for patients,
Two companies, Advanced Cell Technology (ACT) and Geron, both HQ’d here in California, have FDA-approved early stage clinical trials in the works. Geron’s trial has already started and reportedly now has enrolled at least two patients. The trial is of course for the safety of Geron’s GRNOPC1 oligodendrocyte product made from human ES cells for
Advanced Cell Technology and Geron: allies or competitors? Read More »
The McEwen Centre for Regenerative Medicine has launched a new effort they call “Stem Cell City”. As part of the launch they have enlisted the help of Lisa Ray, a Canadian Actress/Model, who was treated for Multiple Myeloma in 2009 using a stem cell transplant. Lisa Ray has a video that is quite compelling (see
Lisa Ray, Stem Cell City, and stem cell resources across the globe Read More »
The ultra right-wing Family Research Council (FRC), a non-scientific organization, today issued a press release slamming the National Science Foundation (NSF), one of the premier scientific organizations in the world over their supposed ignorance about stem cells. What sparked the FRC’s ire was a press release from NSF that discussed a paper in Cell that
Family Research Council angrily calls NSF ignorant about stem cells: reality check! Read More »
How can I make money from stem cells? Someone recently asked me this question and more often I get asked “Which stem cell companies do YOU like as a stem cell scientist?” Just today an article went out that said that the global market for stem cell products will be $65 billion by 2015. That’s
How to make money from stem cells Read More »
Is Cloning Justin Beiber a good idea? Einstein first? Or maybe you? Human cloning is coming. Maybe not to a Walmart near you, but it is coming. And by human cloning, I mean reproductive cloning, not therapeutic cloning which is a totally different cup of tea. The cloning I’m talking about is where you duplicate
Cloning Justin Beiber or Einstein or you? Who’s first? Read More »
I think the iPS cell field is at a crossroads. The next year will be critical for determining the direction for the field. iPS cells have been around almost half as long as human ES cells, so maybe it is no longer appropriate to call the iPS cell field “new”, even though to me it
iPS cell predictions for the next year: yours and mine (take the poll) Read More »
Yamanaka may have found a way to give exogenous Myc the boot from the iPS cell universe. It has always been a frustration in the iPS cell field that Myc, a proto-oncogene, is so important for reprogramming. Yes, you can make iPS cells (especially mouse) without Myc, but it can be orders of magnitude harder,
New iPS cell method: drop Myc or not yet? Read More »
Today, I am launching a new effort called Stem Cell Outreach Program for Education (SCOPE). I think stem cell technology will transform medicine across the globe, but it will take a concerted effort to make certain that stem cell-based therapies do not become a type of medicine only available to the relatively wealthy or predominantly available
Launching SCOPE: Stem Cell Outreach Program for Education Read More »